company-logo

JCR Pharmaceuticals Co., Ltd., a specialty pharmaceuticals company, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V. Infusion used for the treatment of Fabry disease; and TEMCELL HS Inj used to treat acute graft-versus-host disease. The company also develops Epoetin Alfa BS and Darbepoetin Alfa BS Injections for the treatment of renal anemia. In addition, it sells medical devices and laboratory instruments. JCR Pharmaceuticals Co., Ltd. was incorporated in 1975 and is headquartered in Ashiya, Japan.

JCR Pharmaceuticals Dividend Announcement

JCR Pharmaceuticals announced a semi annually dividend of ¥10.00 per ordinary share which will be made payable on 2025-06-01. Ex dividend date: 2025-03-28
JCR Pharmaceuticals's trailing twelve-month (TTM) dividend yield is 3.0%

JCR Pharmaceuticals Dividend History

Ex-Div dateDividend amountDividend typePay date
2025-03-28¥10.00semi annually2025-06-01
2024-09-27¥10.00semi annually2024-12-06
2024-03-28¥10.00semi annually
2023-09-28¥10.00semi annually2023-12-08
2023-03-30¥10.00semi annually2023-06-22
2022-09-29¥10.00semi annually2022-12-09
2022-03-30¥2.00semi annually2022-06-23
2021-09-29¥10.00semi annually2021-12-10
2021-03-30¥0.50semi annually2021-06-24
2020-09-29¥72.00semi annually2020-12-10
2020-03-30¥17.00semi annually2020-06-25
2019-09-27¥15.00semi annually2019-12-10
2019-03-27¥17.00semi annually2019-06-28
2018-09-26¥13.00semi annually2018-12-10
2018-03-28¥14.00semi annually2018-06-28
2017-09-27¥12.00semi annually2017-12-08
2017-03-29¥12.00semi annually2017-06-29
2016-09-28¥10.00semi annually
2016-03-29¥2.00semi annually
2015-09-28¥10.00semi annually
2015-03-27¥10.00semi annually
2014-09-26¥8.50semi annually
2014-03-27¥3.00semi annually

JCR Pharmaceuticals Dividend per year

JCR Pharmaceuticals Dividend growth

JCR Pharmaceuticals Dividend Yield

JCR Pharmaceuticals current trailing twelve-month (TTM) dividend yield is 3.0%. Interested in purchasing JCR Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:

JCR Pharmaceuticals Financial Ratios

P/E ratio-190.54
PEG ratio-1.91
P/B ratio1.46
ROE-0.78%
Payout ratio0.00%
Current ratio1.65
Quick ratio0.98
Cash Ratio0.54

JCR Pharmaceuticals Dividend FAQ

How much is the next JCR Pharmaceuticals dividend?
JCR Pharmaceuticals's board of directors will review the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the next JCR Pharmaceuticals dividend. The next JCR Pharmaceuticals dividend will be released in March, or September.
When is JCR Pharmaceuticals dividend paid?
JCR Pharmaceuticals pays dividends on a semi annually basis. The specific dates may vary each year but are generally around March, and September. However, please note that the exact timing and amount can vary, and companies may also decide to change their dividend policy based on their financial health and other considerations.
What dividend does JCR Pharmaceuticals pay?
The specific amount of JCR Pharmaceuticals dividend can vary from quarter to quarter and year to year, based on a variety of factors including the company's financial performance, the global economic situation, and the decisions of its board of directors. In the above table you can find JCR Pharmaceuticals's dividend history.
Does JCR Pharmaceuticals stock pay dividends?
Yes, JCR Pharmaceuticals does pay dividends to its shareholders. However, the specific amount and frequency of these dividends can vary based on a variety of factors, including the company's financial performance, the global economic situation, and the decisions of its board of directors. In the above table you can find JCR Pharmaceuticals's dividend history.
How much dividend does JCR Pharmaceuticals pay?
JCR Pharmaceuticals paid ¥20.0 in 2024, ¥20.0 in 2023, ¥12.0 in 2022, ¥10.5 in 2021, and ¥89.0 in 2020.
How often does JCR Pharmaceuticals pay dividends?
JCR Pharmaceuticals typically pays dividends on a semi annually basis. This means that dividends are usually distributed 2 times a year. The specific payout dates may vary each year but generally fall around March, and September.
What is JCR Pharmaceuticals's dividend yield?
The current dividend yield for JCR Pharmaceuticals is 3.0%. The dividend yield is calculated by dividing the annual dividend payment by the price of the stock. Both of these numbers can fluctuate daily due to changes in the stock price and any updates to the dividend payment. Use the dividend calculator on this page to calculate JCR Pharmaceuticals's exact dividend yield.
When does JCR Pharmaceuticals go ex dividend?
JCR Pharmaceuticals's ex-dividend date for the latest dividend was on 2025-03-28. JCR Pharmaceuticals typically goes ex-dividend a few weeks before the payment date. The specific dates can vary each year and for each dividend payment.
When is the next JCR Pharmaceuticals dividend paid?
JCR Pharmaceuticals pays dividends on a semi annually basis, typically around March, or September, but the exact dates can vary each year.
Will JCR Pharmaceuticals increase its dividend?
Decisions about dividend payments are made by the company's board of directors and are based on a variety of factors. To understand whether JCR Pharmaceuticals will increase its dividend, it's beneficial to look at the company's earnings, financial health, future business prospects, and the overall economic environment.
How much is JCR Pharmaceuticals dividend per share?
JCR Pharmaceuticals paid ¥20.0 per share in 2024 and ¥20.0 per share in 2023. The amount of dividend per share that JCR Pharmaceuticals pays can vary each quarter based on a range of factors including the company's earnings, financial health, and decisions made by its board of directors.
Is JCR Pharmaceuticals a dividend aristocrat?
No, the term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is JCR Pharmaceuticals a dividend king?
No, a "Dividend King" is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is JCR Pharmaceuticals a dividend stock?
Yes, JCR Pharmaceuticals is considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
Is JCR Pharmaceuticals a good dividend stock?
Whether JCR Pharmaceuticals is a good dividend stock depends on several factors and can vary depending on individual investment goals, risk tolerance, and the overall market conditions. JCR Pharmaceuticals has a history of paying regular dividends, which can make it attractive to income-focused investors.

Other factors to consider when evaluating JCR Pharmaceuticals as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Does JCR Pharmaceuticals pay dividends monthly?
JCR Pharmaceuticals typically pays dividends on a semi annually basis.
Does JCR Pharmaceuticals pay dividends quarterly?
JCR Pharmaceuticals currently pays dividends on a semi annually basis.
Has JCR Pharmaceuticals ever paid a dividend?
Yes, JCR Pharmaceuticals has a history of paying dividends to its shareholders. JCR Pharmaceuticals is known for its dividend payments, which have made it an attractive investment for income-focused investors.
How to buy JCR Pharmaceuticals dividend stocks?
To buy JCR Pharmaceuticals you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees, account minimums, and the availability of dividend reinvestment programs (DRIPs) if you wish to reinvest your dividends automatically.

Place an order: Use the brokerage's trading platform to place an order to buy JCR Pharmaceuticals stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
When does JCR Pharmaceuticals pay dividends 2024?
JCR Pharmaceuticals pays dividends on a semi annually basis. 2024 dividend payments are in 2025-06-01. However, please note that the exact timing and amount can vary, and companies may also decide to change their dividend policy based on their financial health and other considerations.
Will JCR Pharmaceuticals increase its dividend in 2024?
Decisions regarding JCR Pharmaceuticals dividend increases are typically made by a company's board of directors based on various factors, including financial performance, cash flow, investment needs, and market conditions. For an up-to-date JCR Pharmaceuticals dividend overview you can look into the above table of dividend history.
How JCR Pharmaceuticals dividend works?
The JCR Pharmaceuticals dividend works by distributing a portion of the company's profits to its shareholders on a per-share basis. Here's a general overview of how JCR Pharmaceuticals's dividend process works:

1. Determination of Dividend: JCR Pharmaceuticals's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.

2. Dividend Declaration: Once the board approves a dividend, JCR Pharmaceuticals publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.

3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.

4. Payment Date: On the designated payment date, JCR Pharmaceuticals distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.

5. Tax Implications: Dividends received from JCR Pharmaceuticals are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
How are JCR Pharmaceuticals dividends paid?
JCR Pharmaceuticals dividends are typically paid in cash directly to eligible shareholders. The payment process involves the following steps:

1. Record Date: JCR Pharmaceuticals sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.

2. Payment Date: On the designated payment date, JCR Pharmaceuticals distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.

3. Currency: JCR Pharmaceuticals declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
How many times does JCR Pharmaceuticals pay dividends?
JCR Pharmaceuticals typically pays dividends on a semi annually basis. The specific payment dates can vary each year and are usually announced when the company releases its financial results for each quarter.
What months does JCR Pharmaceuticals pay dividends?
The general pattern is that JCR Pharmaceuticals pays dividends around March, and September. However, the exact payment dates can vary each year and are typically announced when the company releases its financial results for each quarter.
Is JCR Pharmaceuticals dividend safe?
The safety of JCR Pharmaceuticals's dividend is subject to various factors and cannot be determined with certainty. It is influenced by the company's financial performance, cash flow, and the overall economic and industry conditions.

To assess the safety of JCR Pharmaceuticals's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.

It is recommended to review JCR Pharmaceuticals's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.